Michael S. Yee

Family Medicine

1000 Franklin Pkwy
3rd Floor Station A
San Mateo, CA 94403

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.

Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 13, 2026

Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community.

Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community.

Journal: PloS one

Published: April 30, 2024

A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.

A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 30, 2023

Screening for NAFLD-Current Knowledge and Challenges.

Screening for NAFLD-Current Knowledge and Challenges.

Journal: Metabolites

Published: March 13, 2023

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.

Journal: International journal of molecular sciences

Published: January 11, 2023

Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease.

Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease.

Journal: The International journal of eating disorders

Published: April 20, 2021

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 21, 2019

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume.

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume.

Journal: Alimentary pharmacology & therapeutics

Published: October 02, 2018

Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.

Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.

Journal: PloS one

Published: August 16, 2018

Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.

Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 07, 2017

Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement.

Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement.

Journal: Clinical endocrinology

Published: December 14, 2015

Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.

Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.

Journal: Frontline gastroenterology

Published: February 21, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026